Christoph Klein studied Medicine (1995) and performed his M.D. thesis at the Ludwig-Maximilians-University in Munich and Toronto at the Ontario Cancer Institute (1998). In Munich (Institute of Immunology, LMU) he continued his work on the development of single cell techniques. In 2001 he received the BioFuture young investigator award to found his own research team. He then joined the University of Regensburg where he became Head of the Division of Oncogenomics in the Department of Pathology in 2006. In 2010 he was appointed Chair of Experimental Medicine and Therapy Research at the University of Regensburg and initiated a Fraunhofer Project Group on Personalized Tumour Therapy. He received the Award of the Dr. Josef Steiner Cancer Foundation in 2011 and the Award of the German Cancer Society in 2014. His work focuses on the characterization of disseminated cancer cells and early metastatic progression to guide the development of adjuvant therapies.
Focus of Scientific Research:
- Biology of metastasis;
- Identification and characterisation of metastasis founder cells and cancer stem cells;
- Development of novel single cell technolgies; identification of therapy target structures